BEN
50
4
JWN
59
11
AON
56
2
NKE
40
4
GOOGL
47
7
TRV
58
2
LRCX
48
5
LH
48
5
PRU
64
2
KO
49
5
NTRS
59
2
IBM
61
3
UPS
64
4
IR
69
3
FRT
50
4
ZION
68
3
BWA
52
4
EXC
57
4
EFX
46
8
GT
65
3
BEN
50
4
JWN
59
11
AON
56
2
NKE
40
4
GOOGL
47
7
TRV
58
2
LRCX
48
5
LH
48
5
PRU
64
2
KO
49
5
NTRS
59
2
IBM
61
3
UPS
64
4
IR
69
3
FRT
50
4
ZION
68
3
BWA
52
4
EXC
57
4
EFX
46
8
GT
65
3
Financhill
Back

Syndax Pharmaceuticals 10K Form

Sell
33

SNDX
Syndax Pharmaceuticals

Last Price:
16.51
Seasonality Move:
21.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q SNDX/Syndax Pharmaceuticals Quarterly
2023-08-03 10Q SNDX/Syndax Pharmaceuticals Quarterly
2023-05-08 10Q SNDX/Syndax Pharmaceuticals Quarterly
2022-11-03 10Q SNDX/Syndax Pharmaceuticals Quarterly
2022-08-08 10Q SNDX/Syndax Pharmaceuticals Quarterly
2022-05-09 10Q SNDX/Syndax Pharmaceuticals Quarterly

Receive SNDX News And Ratings

See the #1 stock for the next 7 days that we like better than SNDX

SNDX Financial Statistics

Sales & Book Value

Annual Sales: $139.71M
Cash Flow: $-62.32M
Price / Cash Flow: 0
Annual Sales: $4.30
Price / Book: 3.9

Profitability

EPS (TTM): -3.63000
Net Income (TTM): $-297.06M
Gross Margin: $0
Return on Equity: -67.33%
Return on Assets: -60.43%

Syndax Pharmaceuticals Earnings Forecast

Key Syndax Pharmaceuticals Financial Ratios

  • The Selling, General & Administrative Expenses for SNDX have been equal to 18.07% of Gross Profit Margin.
  • The Interest Expense is -0.10% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 5 years.

Syndax Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SNDX
CUSIP: 87164F
Website: syndax.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.99
Quick Ratio: 6.92

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SNDX Technical Analysis vs Fundamental Analysis

Sell
33
Syndax Pharmaceuticals (SNDX) is a Sell

Is Syndax Pharmaceuticals a Buy or a Sell?